AL2846
- Generic Name
- AL2846
A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
Phase 1
- Conditions
- Advanced Colorectal Cancer
- Interventions
- First Posted Date
- 2020-04-08
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT04337879
- Locations
- 🇨🇳
The First Hospital of China Medical University, Shengyang, Liaoning, China
A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
Phase 2
- Conditions
- Bone Metastatic Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04325776
- Locations
- 🇨🇳
Anhui Chest Hospital, Hefei, Anhui, China
🇨🇳Quzhou People's Hospital, Quzhou, Zhejiang, China
🇨🇳China-Japan Union Hospital Of Jilin University, Changchun, Jilin, China
A Study of AL2846 on Tolerance and Pharmacokinetics
- First Posted Date
- 2016-05-20
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02779699
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath